Breast Cancer

Research from M.E. Valsecchi and co-authors yields new data on breast cancer

Published in Women's Health Weekly, January 14th, 2010

According to a study from the United States, "We hypothesize that the use of cyclooxygenase (COX)-2 inhibitors in early disease phases could protect against the development of bony metastases. The medical charts of patients with stage II-III breast cancer diagnosed between 1999 and 2005 were reviewed."

"were subdivided according to the use of COX-2 inhibitors after the diagnosis and for >= 6 months. Bivariate analyses were undertaken, and statistically significant variables were included in a multivariate logistic regression model. Eleven percent of patients (74 of 644) who did not use COX-2 inhibitors developed bone metastases compared with 2016 (1 of 48) of those...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2010-01-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry